4'-(2-(1-(carboxymethyl)-5-neopentyl-1H-imidazol-2-yl)ethyl)-3-fluorobiphenyl-2-carboxylic acid

ID: ALA4476111

Chembl Id: CHEMBL4476111

PubChem CID: 155538227

Max Phase: Preclinical

Molecular Formula: C25H27FN2O4

Molecular Weight: 438.50

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  CC(C)(C)Cc1cnc(CCc2ccc(-c3cccc(F)c3C(=O)O)cc2)n1CC(=O)O

Standard InChI:  InChI=1S/C25H27FN2O4/c1-25(2,3)13-18-14-27-21(28(18)15-22(29)30)12-9-16-7-10-17(11-8-16)19-5-4-6-20(26)23(19)24(31)32/h4-8,10-11,14H,9,12-13,15H2,1-3H3,(H,29,30)(H,31,32)

Standard InChI Key:  LLRZUZCSJJVZPG-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4476111

    ---

Associated Targets(Human)

BRS3 Tchem Bombesin receptor subtype-3 (700 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Brs3 Bombesin receptor subtype-3 (412 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 438.50Molecular Weight (Monoisotopic): 438.1955AlogP: 4.85#Rotatable Bonds: 8
Polar Surface Area: 92.42Molecular Species: ACIDHBA: 4HBD: 2
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 2.91CX Basic pKa: 7.54CX LogP: 3.73CX LogD: 0.70
Aromatic Rings: 3Heavy Atoms: 32QED Weighted: 0.52Np Likeness Score: -0.81

References

1. Kiyotsuka Y, Shimada K, Kobayashi S, Suzuki M, Akiu M, Asano M, Sogawa Y, Hara T, Konishi M, Abe-Ohya R, Izumi M, Nagai Y, Yoshida K, Abe Y, Takamori H, Takahashi H..  (2016)  Synthesis and biological evaluation of novel imidazol-1-ylacetic acid derivatives as non-brain penetrant bombesin receptor subtype-3 (BRS-3) agonists.,  26  (17): [PMID:27491709] [10.1016/j.bmcl.2016.07.056]

Source